window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 1, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Global health

  • Artificial Intelligence,Clinical studies,Digital Health,Global health,Oncology,Partnerships & Funding,Women's Health

    SpotitEarly and Hackensack Meridian Health partner to advance early detection with trained dogs

    SpotitEarly, a US-based early cancer detection startup, has announced a [...]

    October 1, 2025
  • Global health,Patient Centricity,Pharmaceuticals and therapeutics

    Kenya, Uganda and Côte d’Ivoire partner with Terumo Blood and Cell Technologies to build coordinated national care frameworks for sickle cell care

    Ministries of Health in Kenya and Côte d’Ivoire, together with [...]

    September 30, 2025
  • Biologics & Biosimilars,Global health,Market Access & Commercialization,Pharmaceuticals and therapeutics,Rare Diseases,Supply Chain & Logistics

    Er-Kim to commercialize Nulibry and Zokinvy across Central and Eastern Europe, Mediterranean and Eurasia

    Er-Kim has signed an agreement with Sentynl Therapeutics to distribute [...]

    September 29, 2025
  • Biologics & Biosimilars,Chronic diseases,Clinical Development,Clinical Trials,Drug Development,Global health,Medical devices,Pharmaceuticals and therapeutics,Regulatory Affairs

    Hansa Biopharma reports statistically significant improvement in kidney function, supporting planned BLA submission

    Hansa Biopharma AB has announced positive topline results from the [...]

    September 26, 2025
  • Global health,Movers & Shakers,Partnerships & Funding

    The Biotech Growth Trust appoints Dame Jenny Harries as non-executive director

    The Biotech Growth Trust has appointed Dame Jenny Harries as [...]

    September 23, 2025
  • Biologics & Biosimilars,Chronic diseases,Clinical Development,Clinical Trials,Global health,Market Access & Commercialization,Medical devices,Patient Centricity,Pharmaceuticals and therapeutics,Regulatory Affairs

    Terumo BCT expands access to rare disease therapies across Latin America

    Terumo Blood and Cell Technologies has announced regulatory approvals for [...]

    September 22, 2025
  • Biotech,Global health,Pharmaceuticals and therapeutics,Research & Development

    MaaT Pharma reports strong Phase 3 results and EMA submission for Xervyteg

    MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotech focused on microbiome-based [...]

    September 22, 2025
  • Clinical Development,Clinical Trials,Global health,Medical devices,Patient Centricity,Regulatory Affairs

    New study shows IntelliSep test improves early sepsis detection and boosts SEP-1 compliance by 29%

    A study presented at the American College of Emergency Physicians [...]

    September 16, 2025
  • Genomics and sequencing,Global health,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    Kling Bio and Sanofi join forces to speed discovery of neutralizing antibodies

    Kling Bio has announced a collaboration and license option agreement [...]

    September 9, 2025
  • Cell & Gene Therapy,Global health,Partnerships & Funding,Pharmaceuticals and therapeutics

    Terumo BCT and PwC Belgium join forces to break barriers in access to advanced cell and gene therapies

    Terumo Blood and Cell Technologies (Terumo BCT), a medical technology [...]

    September 8, 2025
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Regeneron enters radiopharmaceuticals through multi-programme collaboration with Telix in oncology expansion
    Categories: Drug discovery, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Precision medicine, Research & Development, Technology and platforms
  • Pharma firms localise GLP-1 supply chains as shortages and geopolitical risks grow
    Categories: Biomanufacturing, CDMOs & Manufacturing, Drug Development, Manufacturing, Pharmaceuticals and therapeutics, Supply Chain & Logistics
  • Emalex wins US patent for ecopipam ODT as Tourette access program grows
    Categories: Clinical Development, Drug Development, FDA, Neurosciences, Pharmaceuticals and therapeutics, Rare Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top